Found 5 results
| Name | Type of Offering | Accepted Date |
|---|---|---|
|
Alto Neuroscience, Inc.
See All Filings
|
D | 2023-11-27 15:13:21 |
|
Amount To Be Raised
$7,722,217
Associated Brokers / Dealers
N/A
CIK Number
0001999480
Filed Document
0001999480-23-000001
Exclusions or Exemptions
506b
Accepted Date
2023-11-27 15:13:21
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
|
Alto Neuroscience, Inc.
See All Filings
|
D | 2023-11-27 15:20:57 |
|
Amount To Be Raised
$45,000,223
Associated Brokers / Dealers
N/A
CIK Number
0001999480
Filed Document
0001999480-23-000004
Exclusions or Exemptions
506b
Accepted Date
2023-11-27 15:20:57
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
|
Alto Neuroscience, Inc.
See All Filings
|
D | 2023-11-27 15:16:44 |
|
Amount To Be Raised
$31,887,138
Associated Brokers / Dealers
N/A
CIK Number
0001999480
Filed Document
0001999480-23-000002
Exclusions or Exemptions
506b
Accepted Date
2023-11-27 15:16:44
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
|
Alto Neuroscience, Inc.
See All Filings
|
D | 2023-11-27 15:19:02 |
|
Amount To Be Raised
$59,261,815
Associated Brokers / Dealers
N/A
CIK Number
0001999480
Filed Document
0001999480-23-000003
Exclusions or Exemptions
506b
Accepted Date
2023-11-27 15:19:02
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
|
Alto Neuroscience, Inc.
See All Filings
|
D | 2025-10-27 17:17:59 |
|
Amount To Be Raised
$49,999,533
Associated Brokers / Dealers
N/A
CIK Number
0001999480
Filed Document
0001231919-25-000357
Exclusions or Exemptions
506b
Accepted Date
2025-10-27 17:17:59
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
No Revenues
Type of Security
Equity
|
||